These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22574985)

  • 1. CD36 as a therapeutic target for endothelial dysfunction in stroke.
    Cho S
    Curr Pharm Des; 2012; 18(25):3721-30. PubMed ID: 22574985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36: a multi-modal target for acute stroke therapy.
    Cho S; Kim E
    J Neurochem; 2009 May; 109 Suppl 1(Suppl 1):126-32. PubMed ID: 19393018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression.
    Qin L; Kim E; Ratan R; Lee FS; Cho S
    J Neurosci; 2011 Jan; 31(2):775-83. PubMed ID: 21228186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles for the CD36 scavenger receptor as a potential therapeutic target for corneal neovascularization.
    Mwaikambo BR; Yang C; Ong H; Chemtob S; Hardy P
    Endocr Metab Immune Disord Drug Targets; 2008 Dec; 8(4):255-72. PubMed ID: 19075779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Common CD36 Variant Influences Endothelial Function and Response to Treatment with Phosphodiesterase 5 Inhibition.
    Shibao CA; Celedonio JE; Ramirez CE; Love-Gregory L; Arnold AC; Choi L; Okamoto LE; Gamboa A; Biaggioni I; Abumrad NN; Abumrad NA
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2751-8. PubMed ID: 27144937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta.
    Park L; Wang G; Zhou P; Zhou J; Pitstick R; Previti ML; Younkin L; Younkin SG; Van Nostrand WE; Cho S; Anrather J; Carlson GA; Iadecola C
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5063-8. PubMed ID: 21383152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of CD36 in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
    Ueno M; Nakagawa T; Nagai Y; Nishi N; Kusaka T; Kanenishi K; Onodera M; Hosomi N; Huang C; Yokomise H; Tomimoto H; Sakamoto H
    Neuropathol Appl Neurobiol; 2011 Dec; 37(7):727-37. PubMed ID: 21418266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells.
    Kerkhoff C; Sorg C; Tandon NN; Nacken W
    Biochemistry; 2001 Jan; 40(1):241-8. PubMed ID: 11141076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD36 tango in cancer: signaling pathways and functions.
    Wang J; Li Y
    Theranostics; 2019; 9(17):4893-4908. PubMed ID: 31410189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD36 and atherosclerosis.
    Silverstein RL; Febbraio M
    Curr Opin Lipidol; 2000 Oct; 11(5):483-91. PubMed ID: 11048891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36.
    Enenstein J; Gupta K; Vercellotti GM; Hebbel RP
    Exp Cell Res; 1998 Feb; 238(2):465-71. PubMed ID: 9473355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
    Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
    Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.
    Bao Y; Wang L; Xu Y; Yang Y; Wang L; Si S; Cho S; Hong B
    Atherosclerosis; 2012 Jul; 223(1):152-9. PubMed ID: 22658257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.
    Silverstein RL; Febbraio M
    Sci Signal; 2009 May; 2(72):re3. PubMed ID: 19471024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
    Anderson CR; Hastings NE; Blackman BR; Price RJ
    Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease.
    Yokoi H; Yanagita M
    Kidney Int; 2016 Apr; 89(4):740-2. PubMed ID: 26994570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications.
    Tian K; Xu Y; Sahebkar A; Xu S
    Curr Atheroscler Rep; 2020 Aug; 22(10):59. PubMed ID: 32772254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.
    Ren B; Hale J; Srikanthan S; Silverstein RL
    Blood; 2011 Jun; 117(22):6036-45. PubMed ID: 21441463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ligand-independent apoptotic pathway induced by scavenger receptor class B, type I and suppressed by endothelial nitric-oxide synthase and high density lipoprotein.
    Li XA; Guo L; Dressman JL; Asmis R; Smart EJ
    J Biol Chem; 2005 May; 280(19):19087-96. PubMed ID: 15749707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel situations of endothelial injury in stroke - mechanisms of stroke and strategy of drug development: preface.
    Umemura K; Wada K
    J Pharmacol Sci; 2011; 116(1):18. PubMed ID: 21498959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.